Funding News

HealthQuad Just Launched a $300M Fund III — And It Is Betting on AI Health, Chronic Care, and Point-of-Care Devices in India

By BHC, Editor in Chief · April 6, 2026 · 5 min read

BHC, Editor in Chief — HealthQuad Just Launched a $300M Fund III — And It Is Betting on AI Health, Chronic Care, and Point-of-Care Devices in India

Summary

  • HealthQuad has launched a $300 million Fund III targeting AI health, chronic care, and point-of-care devices. This complete guide covers every major healthcare VC and PE fund active in India in 2026.

India's healthcare venture capital ecosystem has a new landmark. HealthQuad — the only dedicated healthcare-only VC platform in India, backed by Quadria Group — has launched its third fund, targeting a corpus of up to $300 million. The fund comprises a $200 million target corpus with a $100 million greenshoe option, and plans to back 13 to 15 startups across AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices.

"India presents one of the world's most compelling healthcare investment opportunities — driven by growing demand, digital acceleration, and underserved segments across primary, diagnostic, and chronic care."

HealthQuad Fund III represents a significant step up from its predecessors. Fund I closed in 2017 at $11.6 million. Fund II closed in 2022 at $162 million, backed by Quadria Capital and KOIS, with MSD (Merck & Co.) as a lead LP. The third fund — now operating under full Quadria Group ownership after its separation from KOIS — signals both the maturation of the Indian healthcare VC ecosystem and the growing conviction among global institutional capital that Indian healthcare innovation deserves a dedicated, specialist investment vehicle.

Across Funds I and II, HealthQuad has built one of India's most credible healthcare portfolios: Qure.ai (AI diagnostics, 13 FDA clearances), Medikabazaar (B2B medical supplies marketplace), Redcliffe Labs (diagnostics), Wysa (AI mental health), BeatO (diabetes management), ekincare (employee wellness), Stanplus (emergency medical services), ImpactGuru (healthcare crowdfunding), and GoApptiv (pharma distribution). The portfolio collectively claims to have impacted 60 million lives.

**What Fund III Is Targeting

Dr Amit Varma, Co-founder of HealthQuad, has articulated the Fund III thesis clearly: India's healthcare investment opportunity is defined by growing demand, digital acceleration, and severely underserved segments across primary, diagnostic, and chronic care. Fund III will invest primarily in India with limited allocation to Southeast Asia and the GCC — expanding the geographic scope while maintaining the core India conviction that has defined the platform.

The six focus areas — AI-driven healthcare, digital therapeutics, ambulatory care, enterprise healthcare SaaS, point-of-care devices, and diagnostics — reflect the convergence of clinical need and commercial scale. AI diagnostics alone, as demonstrated by HealthQuad portfolio company Qure.ai, has proven the viability of Indian AI health companies on a global stage. Digital therapeutics for chronic disease management — diabetes, mental health, hypertension — represent the single largest unmet commercial opportunity in Indian healthcare. And enterprise SaaS for hospital operations is a category that is still massively underserved.

**India's Complete Healthcare VC and PE Directory

For founders raising capital, understanding India's healthcare investment landscape is a competitive advantage. Below is BHC Media's comprehensive directory of every major fund actively investing in Indian healthcare — from dedicated healthcare-only VCs to cross-sector funds with significant health portfolios.

HealthQuad (Quadria Group) is India's dedicated healthcare VC, now on its third fund at $300M. It invests at Series A and B stages in tech-enabled healthcare across India and SEA. Its portfolio spans diagnostics, AI health, mental health, emergency services, and B2B health platforms. Quadria Capital — HealthQuad's parent PE firm — operates separately with a $1B+ AUM growth equity mandate, having backed MediBuddy, Aster DM Healthcare, and Sahyadri Hospitals across South Asia and Southeast Asia.

Bessemer Venture Partners closed its second India-focused fund at $350 million and has been one of the most active international VCs in Indian healthcare — backing Sukino's $31M Series B, PharmEasy, and HealthifyMe. Peak XV Partners (formerly Sequoia India) operates as a multi-sector fund with significant healthcare allocation, having backed Plum (employee health), 1mg, Practo, and Innovaccer. Lightrock India focuses on impact investing with healthcare as a primary sector — backing MediBuddy, BeatO, and Dozee, with ESG frameworks integrated into investment decisions.

Lightspeed India invests across sectors at seed to Series B, with growing healthcare exposure. Alpha Wave Global is a growth and late-stage crossover fund that has participated in healthcare rounds including Even Healthcare and Gut Clinic. W Health Ventures is a healthcare-only VC with a clinical care delivery thesis, backing companies in maternal health (Mylo), weight management (Elevate Now), and B2B care delivery. Rainmatter, the healthcare fund of Zerodha, takes a mission-driven approach backing Sukino, Acko, and Fitterfly — with a focus on companies creating real health outcomes rather than pure tech platforms.

Earlier-stage vehicles include Ankur Capital (impact-focused, primary care and health access), Endiya Partners (early-stage deep tech across MedTech and life sciences), and Blume Ventures (multi-sector with growing digital health allocation). For government grants and non-dilutive funding, BIRAC — the Biotechnology Industry Research Assistance Council — remains the primary mechanism for biotech and MedTech startups at TRL 4 and above.

**How to Think About Approaching Indian Healthcare VCs

The Indian healthcare VC landscape has matured significantly. The generalist VC approach — backing any healthtech startup with a large addressable market and a charismatic founder — no longer works. Specialist funds like HealthQuad, W Health, and Rainmatter evaluate healthcare companies on clinical metrics, patient outcomes, and regulatory strategy, not just user growth and revenue multiples.

For founders approaching healthcare VCs in India: clinical validation matters as much as commercial traction. Regulatory strategy — understanding your CDSCO pathway, your NMC relationships, and your clinical data requirements — is a differentiation, not a compliance burden. And the ability to articulate a specific, defensible thesis about which patient population you serve, at what cost, with what outcomes, is what separates funded from unfunded in this environment.

**BHC Perspective

At Bengaluru Health Community, we track the healthcare VC landscape because our founders and mentors need to understand where capital is coming from and what it is looking for. HealthQuad Fund III is the most important development in Indian healthcare venture capital in 2025 and 2026. Its launch at $300 million signals that India is ready for a truly institutional, specialist healthcare VC ecosystem — not just as a subsector within generalist funds, but as a standalone asset class. The BHC Mentorship Platform is uniquely positioned to connect founders navigating this capital landscape with the investors, clinical experts, and regulatory advisors who can help them build fundable, clinically credible businesses.

**Frequently Asked Questions

Q: What is HealthQuad and what does it invest in?
A: HealthQuad is India's only dedicated healthcare-only VC fund, backed by Quadria Group. Fund III targets $300 million and invests in AI-driven healthcare, digital therapeutics, ambulatory care, enterprise SaaS, and point-of-care devices across India and Southeast Asia.

Q: What companies has HealthQuad backed?
A: Notable HealthQuad portfolio companies include Qure.ai (AI diagnostics), Medikabazaar (B2B medical supplies), Redcliffe Labs (diagnostics), Wysa (AI mental health), BeatO (diabetes), ekincare (employee wellness), and Stanplus (emergency medical services).

Q: Which are the top healthcare VCs in India?
A: Key healthcare VCs in India include HealthQuad, Quadria Capital, Bessemer Venture Partners, Peak XV (Sequoia), Lightrock India, Alpha Wave Global, W Health Ventures, Rainmatter, Ankur Capital, and Endiya Partners — spanning seed to growth equity across all healthcare sub-sectors.